Mydral Side Effects
Generic name: tropicamide ophthalmic
Note: This document contains side effect information about tropicamide ophthalmic. Some of the dosage forms listed on this page may not apply to the brand name Mydral.
Some side effects of Mydral may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to tropicamide ophthalmic: ophthalmic solution
Along with its needed effects, tropicamide ophthalmic (the active ingredient contained in Mydral) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur while taking tropicamide ophthalmic:Symptoms of too much medicine being absorbed into the body
- Clumsiness or unsteadiness
- fast heartbeat
- flushing or redness of face
- hallucinations (seeing, hearing, or feeling things that are not there)
- increased thirst or dryness of mouth
- skin rash
- slurred speech
- swollen stomach in infants
- unusual behavior, especially in children
- unusual drowsiness, tiredness, or weakness
Some side effects of tropicamide ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:More common
- Blurred vision
- sensitivity of eyes to light
- stinging of the eye when the medicine is applied
For Healthcare Professionals
Applies to tropicamide ophthalmic: compounding powder, ophthalmic solution
Ocular side effects associated with tropicamide ophthalmic (the active ingredient contained in Mydral) have included transient stinging, blurry vision, photophobia, and superficial punctate keratitis. Increased intraocular pressure has been reported with mydriatic agents.
Gastrointestinal side effects have included dry mouth, nausea, and vomiting.
Nervous system side effects have included headaches, psychotic reactions, and behavioral disturbances.
Cardiovascular side effects have included pallor, tachycardia, and vasomotor or cardiorespiratory collapse.
Musculoskeletal side effects have included muscle rigidity.
Hypersensitivity reactions (unspecified) have been reported.
More Mydral resources
- Mydral MedFacts Consumer Leaflet (Wolters Kluwer)
- Mydral Ophthalmic Advanced Consumer (Micromedex) - Includes Dosage Information
- Mydriacyl Concise Consumer Information (Cerner Multum)
- Mydriacyl Prescribing Information (FDA)
- Ocu-Tropic Advanced Consumer (Micromedex) - Includes Dosage Information
- Tropicacyl Prescribing Information (FDA)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.